Johnson & Johnson Receives FDA De Novo Authorization For Its OTTAVA Robotic Surgical System
The system received marketing authorization for multiple procedures in general surgery, including Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, small bowel resection, appendectomy,
Johnson & Johnson got official permission to sell a robotic surgery robot that can help doctors do many different belly surgeries more safely and precisely. When a company gets approval for new medical tools, it usually means they can start making money from them and people might trust the company more.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.